Anterra Capital

Animol Discovery focuses on developing innovative veterinary medicines through its proprietary drug discovery technology. The company specializes in creating small molecule active pharmaceutical ingredients tailored for the unique needs of veterinary patients. Utilizing a technology platform built on DNA-encoded chemicals, Animol enables accelerated ultra-high throughput screening processes, allowing for the simultaneous evaluation of target and anti-target activities. This approach aims to streamline the discovery of effective treatments for pets, addressing a significant need in the animal health industry. Led by a team of experts with extensive experience in bringing veterinary drugs to market, Animol is committed to advancing the field of veterinary medicine.

Animol Discovery focuses on developing innovative veterinary medicines through its proprietary drug discovery technology. The company specializes in creating small molecule active pharmaceutical ingredients tailored for the unique needs of veterinary patients. Utilizing a technology platform built on DNA-encoded chemicals, Animol enables accelerated ultra-high throughput screening processes, allowing for the simultaneous evaluation of target and anti-target activities. This approach aims to streamline the discovery of effective treatments for pets, addressing a significant need in the animal health industry. Led by a team of experts with extensive experience in bringing veterinary drugs to market, Animol is committed to advancing the field of veterinary medicine.

Animol Discovery focuses on developing innovative veterinary medicines through its proprietary drug discovery technology. The company specializes in creating small molecule active pharmaceutical ingredients tailored for the unique needs of veterinary patients. Utilizing a technology platform built on DNA-encoded chemicals, Animol enables accelerated ultra-high throughput screening processes, allowing for the simultaneous evaluation of target and anti-target activities. This approach aims to streamline the discovery of effective treatments for pets, addressing a significant need in the animal health industry. Led by a team of experts with extensive experience in bringing veterinary drugs to market, Animol is committed to advancing the field of veterinary medicine.

Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.

Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.

Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.

Animol Discovery focuses on developing innovative veterinary medicines through its proprietary drug discovery technology. The company specializes in creating small molecule active pharmaceutical ingredients tailored for the unique needs of veterinary patients. Utilizing a technology platform built on DNA-encoded chemicals, Animol enables accelerated ultra-high throughput screening processes, allowing for the simultaneous evaluation of target and anti-target activities. This approach aims to streamline the discovery of effective treatments for pets, addressing a significant need in the animal health industry. Led by a team of experts with extensive experience in bringing veterinary drugs to market, Animol is committed to advancing the field of veterinary medicine.